(1.1)  Ra, Weiss. "How Does HIV Cause AIDS?" (1993): n. pag. Web. 20 Mar. 2014.

 

(1.2)  Moore JP, Kitchen SG, Pugach P, Zack, JA. The CCR5 and CXCR4 Coreceptors - Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection. AIDS Research and Human Retroviruses 20(1) 111-126

 

 

(1.3) HIV Cells in Blood Stream, AIDS. N.d. Photograph. n.p. Web. 24 Mar 2014. <http://www.shutterstock.com/pic-62116432/stock-photo-hiv-cells-in-blood-stream-aids.html>

 

(1.4) HIV Cycle. 2012. Frontiers. Web. May 2014. <http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00013/full>.

 

 

(2.1) Cichocki, Mark. "HAART - Highly Active Antiretroviral Therapy." About.com AIDS / HIV. N.p., 9 July 2009. Web. 20 Mar. 2014. <http://aids.about.com/od/hivaidsletterh/g/haartdef.htm>.

 

(2.2) Smith, Dawn K.; Grohskopf, Lisa A.; Black, Roberta J.; Auerbach, Judith D.; Veronese, Fulvia; Struble, Kimberly A. (21 January 2005). "Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States". cdc.gov. Centers for Disease Control. Retrieved 20 March 2014.

 

(2.3) Pills. N.d. Red Med Box. Web. 20 Mar. 2014. <http://redmedbox.com/about.php>.

 

(2.4) Post-Exposure Prohylaxis. 2013. AIDS.gov. Web. 20 Mar. 2014. <http://aids.gov/hiv-aids-basics/prevention/reduce-your-risk/post-exposure-prophylaxis/>.

 

(3.1) CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2011. HIV Surveillance Supplemental Report 2013;18(No. 5). Published October 2013

 

(3.2) U.S. Statistics. 2013. AIDS.gov. Web. 20 Mar. 2014. <http://aids.gov/hiv-aids-basics/hiv-aids-101/statistics/>.

 

(3.3) Estimated HIV Statistics. 2013. AIDS.gov. Web. 20 Mar. 2014. <http://aids.gov/hiv-aids-basics/hiv-aids-101/statistics/>.

 

(4.1) WebMD. Expanding HIV and AIDS Drug Options. http://www.webmd.com/hiv-aids/guide/aids-hiv-medication (accessed January 29, 2014)

 

(4.2) "Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)." Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs). N.p., 31 Jan. 2012. Web. 20 Mar. 2014.

 

(4.3) Morier, Douglas. "Reverse Transcriptase (enzyme)." Encyclopedia Britannica Online. Encyclopedia Britannica, n.d. Web. 20 Mar. 2014.

 

(4.4) M. Rowley, “The Discovery of Raltegravir, an Integrals Inhibitor for the Treatment of HIV Infection,” Progress in Medicinal Chemistry, Vol. 46, No. 5, 2008, pp. 1-28.

 

(4.5) F. Goebel, A. Yakovlev, A. L. Pozniak, E. Vinogradova, G. Boogaerts, R. Hoetelmans, M. P. Béthune, M. Peeters and B. Woodfall, “Short-Term Antiviral Activity of TMC278—A Novel NNRTI—In Treatment-Naive HIV- 1-Infected Subjects”, AIDS, Vol. 20, No. 13, 2006, pp. 1721-1726.

 

(4.6) International Conference on Harmonisation, “Stability Testing of New Drug Substances and Products Q1A (R2),” International Federation of Pharmaceutical Manufacturers Associations, Geneva, 2003.

 

(4.7) HIV Replication. N.d. NIH. Web. 20 Mar. 2014

 

(4.8) HIV and AIDS Tutorial. N.d. HIV and AIDS Tutorial. Web. 20 Mar. 2014. <http://www.biology.arizona.edu/immunology/tutorials/aids/treatment.html>.

 

(4.9) HIV and AIDS Tutorial. N.d. HIV and AIDS Tutorial. Web. 25 Mar. 2014. <http://www.biology.arizona.edu/immunology/tutorials/aids/treatment.html>.

 

(4.10) HIV Treatment. N.d. HIV and AIDS Treatment. Web. 20 Mar. 2014

 

(4.11) Panel on Clinical Practices for Treatment of HIV; Dybul, M; Fauci, AS; Bartlett, JG et al. (2002)."Guidelines for using antiretroviral agents among HIV-infected adults and adolescents". Annals of Internal Medicine 137 (5 Pt 2): 381–433.

 

(4.12) Thompson, MA; Aberg, JA; Hoy, JF; Telenti, A et al. (2012). "Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel".

 

(5.1) Immune Cells Can Repel Attacks from HIV by Starving the Virus, Say Scientists Read More: Http://www.bellenews.com/2012/02/12/science-tech/immune-cells-can-repel-attacks-from-hiv-by-starving-the-virus-say-scientists/#ixzz2wzaONyM1 Follow Us: @bellenews on Twitter | TopDailyNews on Facebook. N.d. Belle News. Web. 20 Mar. 2014. <http://www.bellenews.com/2012/02/12/science-tech/immune-cells-can-repel-attacks-from-hiv-by-starving-the-virus-say-scientists/> 

 

(6.1) Barlett, JD (2006). "Ten years of HAART: Foundation for the Future". Medscape.

 

 

(6.2) Broder, S. (2009). "The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic". Antiviral Research 85

 

(6.3) Photographer from Rockefeller University

 

(6.4) Photographer from Rockefeller University

 

(6.5) "Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)."Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs). N.p., 31 Jan. 2012. Web. 20 Mar. 2014.

 

(7.1) The Joint WHO/ILO Expert Consultation for the Development of Policy and Guidelines on Occupational and Non-occupational HIV Post-exposure Prophylaxis (2005).

 

(7.2) "For Consumers." FDA Approval of New Formulation of Kaletra. N.p., n.d. Web. 25 Mar. 2014. <http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124816.htm>.

 

(7.3) Younglai EV, Holt D, Brown P, Jurisicova A, Casper RF (September 2001). "Sperm swim-up techniques and DNA fragmentation". Hum. Reprod.

 

(8.1)

 

(8.2)  "Dallas Buyers Club - Official Trailer." YouTube. YouTube, 23 Oct. 2013. Web. 20 Mar. 2014. <http://www.youtube.com/watch?v=cC6mv0KhOBY>.

 

(8.3)  "Magic Johnson Announces Retirement Nov 7, 1991." YouTube. YouTube, 19 June 2007. Web. 20 Mar. 2014. <http://www.youtube.com/watch?v=iSfy4AhDDnw>.

 

(9.1) "Inventor of Anti-HIV Drug Dies." Yale Alumni Magazine. N.p., n.d. Web. 25 Mar. 2014. <http://www.yalealumnimagazine.com/articles/3212>.

 

(9.2) "Bernie Sanders." Sen. N.p., n.d. Web. 25 Mar. 2014. <http://www.sanders.senate.gov/newsroom/recent-business/sanders-end-hiv/aids-drug-monopolies>.

 

(9.3) "The Magazine of the Mizzou Alumni Association MIZZOU." MIZZOU Magazine. N.p., n.d. Web. 25 Mar. 2014. <http://mizzoumag.missouri.edu/2013/05/aids-research/>.